Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Clinical chemistry (Baltimore, Md.), 2018-07, Vol.64 (7), p.1006-1033 [Peer Reviewed Journal]

2018 American Association for Clinical Chemistry. ;COPYRIGHT 2018 American Association for Clinical Chemistry, Inc. ;Copyright American Association for Clinical Chemistry Jul 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1373/clinchem.2018.287037 ;PMID: 29760220

Full text available